Amicus Therapeutics is a biotechnology company that is based in New Jersey.
Amicus is also known as a biopharmaceutical company. This e that all the drugs
that it makes are based on natural or organic ingredients. The origin of these drugs are not man-made or inorganic.
Amicus Therapeutics has a number of drugs in the pipeline that deal with catastrophic rare and orphan driseases. Right now, the company is a strong believer in its lead drug called migalastat HCl that can be used alone or in combination with the enzyme replacement therapy to help people with Fabry disease. The company also has deep hopes for another drug in the pipeline called SD-101 that is will help people with rare connective tissue disorder otherwise known as Epidermolysis Bullosa (EB). Chaperone-Advance Replacement Therapeutics (CHART) is another product in the pipeline that that will deal Fabry disease Pompe disease and lyosomal storage disorders (LSDs)
One unique part of Amicus is Amicus Patient and Professional Advocacy. It works with patients, doctors, caregivers and other groups to support and deal with the unique problems that the rare disease community. Whatever challenges that this community faces in the future, this advocacy will be there to face them. This group wants to act as bridge between patients and whatever they need to make their lives easier in a short time that they have on this planet. If a person has a rare disease, this group will be there to help them. Visit Market Watch to know more about Amicus Therapeutics.
John F. Crowley, the Chairman and CEO of Amicus, believes his company is on the cutting edge of dealing with rare, catastrophic diseases. His team has a vision for how to deal with rare diseases in the future.
Crowley wants to make sure that the technology does not make them heartless. No matter how far advanced the technology is, he wants to make sure that the company remains compassionate when dealing with patients, caregivers and families.
The main goal of Amicus seems to be to be far advanced with the drugs, but still have a heart. Learn more about job offerings of Amicus Therapeutics at indeed.com.